Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN)

Objective: As associations between endogenous sex hormones and the vasculature are not well characterized, the objective was to examine the cross-sectional associations of menopausal status and endogenous sex hormones with vascular characteristics. Design: Common carotid artery adventitial diameter and intima-media thickness were determined using B-mode ultrasonography among 483 middle-aged women enrolled in the Pittsburgh and Chicago sites of the Study of Women's Health Across the Nation. Results: Sixty-two percent of women were pre- or early perimenopausal (<3 mo amenorrhea), 12% were late perimenopausal (3-12 mo amenhorrhea), and 27% were postmenopausal (≥12 mo amenorrhea). After adjustment for age, compared with pre-/early perimenopause, late perimenopause was associated with a 0.28-mm larger adventitial diameter (P = 0.001), whereas postmenopause was associated with a 0.15-mm larger adventitial diameter (P = 0.040). Adjustment for traditional cardiovascular risk factors slightly attenuated these associations, but the association with late perimenopause remained statistically significant (P = 0.001). Each SD lower log estradiol value was associated with a 0.07-mm larger adventitial diameter after adjustment for traditional cardiovascular risk factors (P = 0.023), whereas other endogenous hormones showed no associations. Intima-media thickness values were not significantly associated with menopausal status or endogenous sex hormones after adjustment for age. Conclusions: The menopausal transition and declining estrogen levels are associated with alterations of the peripheral vasculature, which may help to explain the increased risk of cardiovascular disease with postmenopause.

[1]  J. Manson,et al.  Estrogen therapy and coronary-artery calcification. , 2007, The New England journal of medicine.

[2]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[3]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[4]  R A Kronmal,et al.  Compensatory increase in common carotid artery diameter. Relation to blood pressure and artery intima-media thickness in older adults. Cardiovascular Health Study. , 1996, Stroke.

[5]  S Hulley,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[6]  S Glagov,et al.  Shear stress regulation of artery lumen diameter in experimental atherogenesis. , 1987, Journal of vascular surgery.

[7]  J. Manson,et al.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. , 2007, JAMA.

[8]  M. Szklo,et al.  Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. , 2002, American journal of epidemiology.

[9]  P. Touboul,et al.  Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. , 1996, Stroke.

[10]  C. Lyttle,et al.  The Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor-κB in HepG2 Cells. , 2000, Endocrinology.

[11]  W. Kannel,et al.  Menopause and risk of cardiovascular disease: the Framingham study. , 1977, Annals of internal medicine.

[12]  Diederick E Grobbee,et al.  Common Carotid Intima-Media Thickness and Risk of Acute Myocardial Infarction: The Role of Lumen Diameter , 2005, Stroke.

[13]  E. Barrett-Connor,et al.  Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women , 1995, BMJ.

[14]  A. Quyyumi,et al.  Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. , 1994, Circulation.

[15]  C. Otto Cardiovascular Health and Disease in Women , 1994 .

[16]  Donald Lloyd-Jones,et al.  Sex Hormone–Binding Globulin and the Free Androgen Index Are Related to Cardiovascular Risk Factors in Multiethnic Premenopausal and Perimenopausal Women Enrolled in the Study of Women Across the Nation (SWAN) , 2005, Circulation.

[17]  R. Karas,et al.  Is the WHI relevant to HRT started in the perimenopause? , 2004, Endocrine.

[18]  A. Whittemore,et al.  Menopause and the risk of coronary heart disease in women. , 1987, The New England journal of medicine.

[19]  Endogenous androgens and carotid intimal-medial thickness in women. , 1999, The Journal of clinical endocrinology and metabolism.

[20]  D. K. Rorie,et al.  Effects of estradiol on release and disposition of norepinephrine from nerve endings. , 1980, The American journal of physiology.

[21]  R. Karas,et al.  Molecular and Cellular Basis of Cardiovascular Gender Differences , 2005, Science.

[22]  G. Garcı́a-Cardeña,et al.  17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. , 1997, Circulation research.

[23]  J. Price,et al.  Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study , 1997, Steroids.

[24]  Lewis H Kuller,et al.  A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries. , 2004, Journal of the American College of Cardiology.

[25]  David Handelsman,et al.  Androgens and cardiovascular disease. , 2003, Endocrine reviews.

[26]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[27]  S. Crawford,et al.  Design, survey sampling and recruitment methods of SWAN: A multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition , 2000 .

[28]  M. Chappell,et al.  Estrogen regulation of angiotensin-converting enzyme mRNA. , 1999, Hypertension.

[29]  M. Jensen-Urstad,et al.  Carotid artery diameter correlates with risk factors for cardiovascular disease in a population of 55-year-old subjects. , 1999, Stroke.

[30]  W Riley,et al.  Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. , 1996, Stroke.

[31]  J. Puolakka,et al.  Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. , 1995, The Journal of clinical endocrinology and metabolism.

[32]  C. Lyttle,et al.  The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. , 2000, Endocrinology.